Endothelin-1 And Procollagen Type-1 Carboxy-terminal Propeptide Are Associated With Functional Tolerance And Cardiac Structure And Function In Heart Failure With Preserved Ejection Fraction

被引：0
|
作者：
Imran, Tasnim F.
Garrett, Thomas
Parra, Laura
Arcuri, Daniel
Nguyen, Christopher
Jankowich, Matthew
Avazmohammadi, Reza
Atalay, Michael
Wu, Wen-Chih H.
Choudhary, Gaurav
机构：
来源：
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2023年 / 43卷
关键词：
Heart failure; 6 Minute Walk; Biomarkers;
D O I：
10.1161/atvb.43.suppl_1.245
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A245
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction
    Osokina, Anastasia
    Karetnikova, Viktoria
    Polikutina, Olga
    Ivanova, Anna
    Gruzdeva, Olga
    Dyleva, Yulia
    Kokov, Aleksandr
    Brel, Natalia
    Pecherina, Tamara
    Barbarash, Olga
    AGING-US, 2021, 13 (01): : 194 - 203
  • [32] GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction
    T. Dung Nguyen
    Yasushige Shingu
    Paulo A. Amorim
    Christina Schenkl
    Michael Schwarzer
    Torsten Doenst
    Journal of Cardiovascular Translational Research, 2018, 11 : 259 - 267
  • [33] GLP-1 Improves Diastolic Function and Survival in Heart Failure with Preserved Ejection Fraction
    Nguyen, T. Dung
    Shingu, Yasushige
    Amorim, Paulo A.
    Schenkl, Christina
    Schwarzer, Michael
    Doenst, Torsten
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2018, 11 (03) : 259 - 267
  • [34] THE EFFECTS OF EMPAGLIFLOZIN AND ORAL KETONE ESTER ON CARDIAC FUNCTION, STRUCTURE, AND METABOLISM IN HEART FAILURE WITH PRESERVED EJECTION FRACTION
    Yurista, Salva
    Jiang, William
    Eder, Robert
    Chen, Shi
    Liu, Feiyang
    Weigand-Whittier, Jonah
    Bedoya, David Guarin
    Yen, Yi-Fen
    Nguyen, Christopher
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 330 - 330
  • [35] Leisure Activity is Associated With Prognosis in Heart Failure With Preserved Ejection Fraction - Results From the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial
    Hegde, Sheila M.
    Shah, Amil M.
    Claggett, Brian
    Anand, Inder S.
    Shah, Sanjiv J.
    Sweitzer, Nancy K.
    Pfeffer, Marc A.
    Solomon, Scott D.
    CIRCULATION, 2015, 132
  • [36] Effect and mechanism of Adipokine Omentin-1 on cardiac hypertrophy in heart failure with preserved ejection fraction
    Li, Q. X.
    Liu, Z. Q.
    Ma, X. T.
    Wang, Z. J.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [37] Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction
    Mascherbauer, Julia
    Marzluf, Beatrice A.
    Tufaro, Caroline
    Pfaffenberger, Stefan
    Graf, Alexandra
    Wexberg, Paul
    Panzenboeck, Adelheid
    Jakowitsch, Johannes
    Bangert, Christine
    Laimer, Daniela
    Schreiber, Catharina
    Karakus, Gultekin
    Huelsmann, Martin
    Pacher, Richard
    Lang, Irene M.
    Maurer, Gerald
    Bonderman, Diana
    CIRCULATION-CARDIOVASCULAR IMAGING, 2013, 6 (06) : 1056 - 1065
  • [38] ENDOGENOUS ENDOTHELIN-1 PARTICIPATES IN THE MAINTENANCE OF CARDIAC-FUNCTION IN RATS WITH CONGESTIVE-HEART-FAILURE - MARKED INCREASE IN ENDOTHELIN-1 PRODUCTION IN THE FAILING HEART
    SAKAI, S
    MIYAUCHI, T
    SAKURAI, T
    KASUYA, Y
    YAMAGUCHI, I
    GOTO, K
    SUGISHITA, Y
    CIRCULATION, 1995, 92 (08) : 871 - 871
  • [39] Cardiac structure and function and prognosis in heart failure with preserved ejection fraction: Findings from the echocardiographic study of the TOPCAT trial
    Shah, A.
    Sweitzer, N.
    Shah, S.
    Anand, I.
    Claggett, B.
    Assmann, S.
    Sopko, G.
    Pitt, B.
    Pfeffer, M.
    Solomon, S.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1030 - 1030
  • [40] Relationship between endothelin-1, heart failure with reduced ejection fraction and dapagliflozin: findings from DAPA-HF
    Yeoh, S. E.
    Docherty, K. F.
    Jhund, P. S.
    Hammarstedt, A.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Solomon, S. D.
    Sattar, N.
    Welsh, P.
    Sabatine, M. S.
    Morrow, D. A.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 833 - 833
12345